Monash University

Patients with systemic lupus erythematosus receiving anifrolumab are more likely to achieve earlier, more frequent and longer low disease activity, compared with those taking placebo, according to data.

Higher HDL levels may be associated with increased fracture risk for older adults independent of other risk factors, according to a post hoc analysis of the ASPREE study.

Risankizumab improves symptoms and is well tolerated through 52 weeks in patients with psoriatic arthritis who respond inadequately to biologic therapies or conventional synthetic disease-modifying antirheumatic drugs, according to data.

Low-dose aspirin for primary prevention of CV events may benefit older adults with elevated lipoprotein(a)-associated genotypes, according to a new analysis of the ASPREE trial.

Early posttraumatic seizures following moderate to severe TBI were linked to poorer in-hospital and long-term outcomes, including posttraumatic epilepsy, according to an Australian registry-based cohort study published in JAMA Neurology.

Anifrolumab improves systemic lupus erythematosus disease activity across musculoskeletal, mucocutaneous and immunological domains, according to a post-hoc analysis of TULIP-1 and TULIP-2 data published in The Lancet Rheumatology.

Every 5°C increase in daily mean temperature correlated with a 6% increase in hospitalization due to diabetes in Brazil between 2000 and 2015.

Women with polycystic ovary syndrome gained more weight annually than those without PCOS, and some lifestyle factors had a greater impact on weight gain with PCOS, according to study data.

Individuals with serious mental illness had high hepatitis C virus prevalence, according to results of a systematic review and meta-analysis published in Journal of Clinical Psychiatry.

Women with irregular menses are 20% more likely to develop cardiovascular disease and 17% more likely to develop type 2 diabetes over 20 years compared with women with regular menstrual cycles, according to an Australian database analysis.